Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sorrento Therapeutics Inc. buy yester

Start price
€8.17
21.09.20 / 50%
Target price
€12.00
02.11.20
Performance (%)
-24.15%
End price
€6.20
02.11.20
Summary
This prediction ended on 02.11.20 with a price of €6.20. The price of Sorrento Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.15%. yester has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Sorrento Therapeutics Inc. - - - -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to yester what are the pros and cons of Sorrento Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Cons

Comments by yester for this prediction

In the thread Sorrento Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -24.15%
Target price 12.000
Change
Ends at 02.11.20

Buy mit Kursziel 12,0

In the thread Trading Sorrento Therapeutics Inc.
Prediction Buy
Perf. (%) -24.15%
Target price 12.000
Change
Ends at 02.11.20

Buy beendet

Stopped prediction by yester for Sorrento Therapeutics Inc.

buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.15
02.11.20
€13.00
04.11.21
-4.96%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.20
02.11.20
€5.00
02.11.20
-0.74%
02.11.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.60
08.09.20
€7.00
21.09.20
46.07%
21.09.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation